Home/Filings/4/0001209191-16-122738
4//SEC Filing

Eiger BioPharmaceuticals, Inc. 4

Accession 0001209191-16-122738

CIK 0001305253operating

Filed

May 22, 8:00 PM ET

Accepted

May 23, 6:37 PM ET

Size

9.2 KB

Accession

0001209191-16-122738

Insider Transaction Report

Form 4
Period: 2016-05-19
Shaffer James P
Chief Business Officer
Transactions
  • Purchase

    Common Stock

    2016-05-19$19.52/sh+500$9,760500 total
  • Purchase

    Common Stock

    2016-05-23$19.99/sh+745$14,8931,245 total

Issuer

Eiger BioPharmaceuticals, Inc.

CIK 0001305253

Entity typeoperating

Related Parties

1
  • filerCIK 0001305253

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 6:37 PM ET
Size
9.2 KB